Physician profile
Assaf Gordon
NPI 1457549156
$9,348.42
in general payments reported to CMS, 2019-2025
54 companies · $1,068 in 2025
The $1,068 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,559 · 2020: $659 · 2021: $948 · 2022: $1,852 · 2023: $2,027 · 2024: $1,236 · 2025: $1,068.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,330.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,304.26 | 2019-2025 | Wavewriter Alpha Prime 16, Infinion 16, Intracept Rf Probe |
| Abbott Laboratories | $1,155.51 | 2019-2025 | Proclaim, Eterna |
| Abbvie INC. | $769.29 | 2022-2025 | |
| Collegium Pharmaceutical, INC. | $606.54 | 2019-2025 | Xtampza, Belbuca |
| Medtronic, INC. | $563.14 | 2021-2024 | Intellis Adaptivestim, Ascenda, Synchromedii |
| Scilex Pharmaceuticals INC. | $426.31 | 2019-2022 | |
| Nevro Corp. | $390.04 | 2019-2024 | Senza |
| Stryker Corporation | $338.16 | 2022-2024 | Spinejack, Mild Device Kit |
| Medtronic USA, INC. | $261.58 | 2019-2020 | |
| Si-Bone, INC. | $252.65 | 2021-2024 | |
| Nalu Medical, INC. | $244.58 | 2022-2024 | Nalu Neurostimulation System |
| Biotronik Nro, INC. | $210.84 | 2024-2025 | Prospera |
| Stimwave Technologies Incorporated | $195.03 | 2019-2021 | |
| Foundation Fusion Solutions, LLC | $191.67 | 2022 | |
| Mml US, INC. | $190.33 | 2023-2025 | Reactiv8 |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Assaf Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.